Metabolic biomarker profiling of chronic disease risk in the Finnish population

Nightingale Health Oyj has developed a biomarker profiling technology widely used in population health research. Nightingale has measured biomarkers from ~40,000 samples from THL biobank cohorts. The aim of this THL Biobank project is to continue research on the existing NMR biomarker data for precision medicine research. The research will also help further developments of this technology in healthcare settings. The project duration has been extended by THL Biobank.

Lupaan tehdyt muutokset: Voimassaolon jatkaminen; Käsittelijöiden muuttaminen

Alkuperäisen luvan myöntäjä: Findata, THL, Kela, Tilastokeskus